Walmart will replace AstraZeneca in the Nasdaq-100 Index on January 20 following its move from the NYSE. The shift aligns with Walmart’s st...

AstraZeneca Pharma India shares saw a rise after Imfinzi got approval for expanded use. The CDSCO approved it as a first-line treatment for...

President Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries, setting pric...

Several stocks in the S&P BSE 500 index, including Angel One, AstraZeneca Pharma, and Bajaj Finance, achieved new 52-week highs, reflecting...

Several BSE Smallcap stocks reached their 52-week high and generated market excitement. AstraZeneca Pharma, Apar Industries, Force Motors, ...

Several companies in S&P BSE Smallcap stocks have approached their 52-week high levels, including Arvind, Kirloskar Industries, Waaree Rene...

Several S&P BSE Smallcap stocks, including Arvind, Kirloskar Industries, Waaree Renewable Technologies, AstraZeneca Pharma, Safari Industri...

ETMarkets has identified five stocks with a Golden Crossover, indicating potential growth opportunities. These companies have a market capi...

In a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...

When including production and distribution from partners such as the Serum Institute of India, more than 300 million doses have been suppli...

The S&P/ASX 200 index slipped 0.3 per cent to 6,974, closing lower for the second straight session. Last week, it had posted its best weekl...

The S&P/ASX 200 index settled 0.1 per cent lower at 6,995.2 points at close of trade, applying brakes on its longest winning run since earl...

Nakayama decided to reboot Daiichi Sankyo, pivoting toward the more lucrative business of cancer drugs.

The company said its net sales for the quarter ended June 30 jumped 15.1 per cent YoY to Rs 138.10 crore, compared with Rs 120.03 crore yea...

AZ had asserted that its purple coloured pill is protected by three federal trademarks and the generic drug launched by Dr Reddy’s in Septe...

A continuous improvement in earnings on sequential basis will continue and pharma stocks may keep on performing well, believes Quantum Secu...

ET Now caught up with Sharmila Joshi, Co-Head PCG Sales, Emkay Global Financial Services, to get her views on the outlook of Torrent Pharma.